Ferit GURSU, Erhan ONALAN, İhsan SOLMAZ, Buray YAKAR, Mesut KILIÇOĞLU

The relationship between betatrophin levels and HbA1c: A case control study

Aim: In our study, we first aimed to investigate the effect of betatrophin in uncontroled diabetes patients with HbA1c above 14.Another focus of our study is the effect of betatrophin levels on the biochemical parameters of the patients.Material and Methods: This is an observational study with a prospective case-control design. The study was carried out betweenJuly 2018 and November 2018 at the internal medicine clinic of the tertiary university hospital. Our study was conducted withparticipants divided into 3 groups. Group 3 (uncontrolled T2DM) consisted of 40 participants who met the study criteria and HbA1cabove 14% . Group 2 (controlled T2DM) consisted of 40 participants who met the study criteria and HbA1c below %10 and the group1 (control group) consisted of 40 people who did not have a history of diabetes mellitus.Results: There was no statistical difference in age and sex between the 3 groups included in the study. Betatrophin levels of patientswith uncontrolled diabetes were significantly higher than control group and controlled diabetic group.(p

PDF

___

1. Glisemik Bozukluklarda Tanı, Sınıflama ve Tarama. TEMD Diyabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu. 12. Baskı, Türk Endokrinoloji ve Metabolizma Derneği, 2019:15-27.
2. Crandall J and Shamoon H. Diabetes Mellitus. In: Lee G, Andrew IS, eds. GoldmanCecil Medicine. 25. Edition,Philadelphia, Elsevier Saunders 2016:1527- 48.
3. Yi P, Park JS, Melton DA. Betatrophin: A hormone that controls pancreatic beta cell proliferation. Cell 2013;153:747-58.
4. Chen J, Chen S, Huang P, et al. In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats. Diabetologia 2015;58:1036-44.
5. Jiao Y, Le Lay J, Yu M, et al. Elevated mouse hepatic betatrophin expression does not increase human beta-cell replication in the transplant setting. Diabetes 2014;63:1283-8.
6. Zhang Y, Li S, Donelan W, et al. Angiopoietin-like protein 8 (betatrophin) is a stress-response protein that down-regulates expression of adipocyte triglyceride lipase. Biochim Biophys Acta 2016;1861:130-7.
7. Zhang R. Lipasin, a novel nutritionally-regulated liverenriched factor that regulates serum triglyceride levels, Biochem Biophys Res Commun 2012;424;786- 92.
8. Gokulakrishnan K, Manokaran K, Pandey GK, Amutha A, Ranjani H, Anjana RM, et al. Relationship of betatrophin with youth onset type 2 diabetes among Asian Indians. Diabetes Res Clin Pract 2015;109:71-6.
9. Gomez-Ambrosi J, Pascual E, Catalan V, , et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metabol 2014;99: 2004-9.
10. Hu H, Sun W, Yu S, et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 2014;37:2718-22.
11. Chen X, Lu P, He W, et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab 2015;100:96-100.
12. Espes D, Martinell M. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014;2014:323407.
13. Sheyu Li, Dan Liu, Ling Li, et al. “Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis,” Journal of Diabetes Research. 2016;2016:9
14. Fenzl A, Itariu BK, Kosi L, F et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia. 2014;57:1204-8.
15. Ebert T, Kralisch S, Hoffmann A, et al. Circulating angiopoietin-like protein 8 is independently associated with fasting plasma glucose and type 2 diabetes mellitus. J Clin Endocrinol Metab 2014;99:2510-17.
16. Song Yue, Jingyang Wu, Jiahua Zhang, et al. “The Relationship between Betatrophin Levels in Blood and T2DM: A Systematic Review and Meta-Analysis,” Disease Markers, 2016;2016:7.
17. Hassan AB1, Salih SF2, Hassan II3, Saadi FS4, Abdulah DM5, Ahmed IH6, Taher SM7, Khaleel BB8. Circulating betatrophin in relation to metabolic, inflammatory parameters, and oxidative stress in patients with type 2 diabetes mellitus. Diabetes Metab Syndr 2019;13:458-63.
18. Takebayashi K, Hara K, Terasawa T, et al. Serum Betatrophin Levels and Clinical Features in Patients With Poorly Controlled Type 2 Diabetes. J Clin Med Res. 2017;9:782-7.
19. Al-Daghri NM, Rahman S, Sabico S, Amer OE, Wani K, Ansari MG, Al-Attas OS, Kumar S, Alokail MS. Circulating betatrophin in healthy control and type 2 diabetic subjects and its association with metabolic parameters. J Diabetes Complications 2016;30:1321- 5.
20. Daniel E, Mats M, Per-Ola C. Increased Circulating Betatrophin Concentrations in Patients with Type 2 Diabetes. Inter J Endocrinology 2014:6.
21. Zhou J-Z, Li C-X, Dai Y-N, et al. Serum betatrophin level increased in subjects with metabolic syndrome: a case-control study. Nutr Hosp 2016;33:303-9.